Central venous access devices (CVADs) can facilitate repeated and/or urgent administration
of coagulation factors in haemophilic patients. We conducted a systematic review and meta …

Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed ubiquitously
throughout the body. Thus, while respiratory manifestations dominate much of cystic fibrosis …

Malignancy is the most common cause of the superior vena cava (SVC) syndrome. With the
increasing use of intravascular devices, the incidence of the SVC syndrome arising from …

Objective: Previous studies estimated the incidence of catheter-associated venous
thrombosis to be between 2% and 81%. Our goals were to define the incidence rate of …

The incidence of venous thromboembolism (VTE) is increasing in the pediatric population.
Individuals with cystic fibrosis (CF) have an increased risk of thrombosis due to central …

The healthy adolescent will encounter major changes in biological and psychosocial
domains. The adolescent period can be greatly affected by a chronic illness. Cystic fibrosis …

Implanted subcutaneous (sc) central venous port accesses including Port-A-Cath (PAC)
facilitate the administration of chemotherapy or blood products and are frequently used in …

PURPOSE: Peripherally inserted central catheters (PICCs) are commonly used in patients
with cystic fibrosis (CF) to administer intravenous antibiotics for pulmonary exacerbations …

Rationale: Peripherally inserted central catheters (PICCs) are common in the treatment of
patients with cystic fibrosis (CF). Previous reports suggest that patients with CF are at …

Introduction: Cystic fibrosis (CF) is a genetic disease that primarily affects the respiratory
system and often leads to respiratory failure and premature death. Although pulmonary …